Oncology Clinical Trial Experience

Our clinical team members and medical personnel have critical first-hand experience in the complex issues often associated with oncology clinical trials, which means that highly experienced resources will be working on your study.

Whether it’s a standard dose-escalation phase I trial or a complex rescue of a phase III trial, chances are that our team has handled it before.

Our Quality, Timeline and Budget Metrics

Since our inception, Medelis has achieved:

  • 96% of projects on budget
  • 91% of projects completed on time
  • Zero (0) critical findings noted in audits

Indications, sponsor types and geographic experience

  • Our team has managed phase I through phase IIIs in the US, Canada and Europe.
  • We offer extensive EDC experience including usage in those phase I trials that need to carefully balance costs and reporting speed.
  • We’ve worked with all different sponsor types: public and private, biotech and pharmaceutical, governmental, large and small, European and U.S.
  • We’ve handled most targets within oncology:
  • Acute myeloid leukemia (AML)
  • Bone marrow transplant
  • Breast
  • Cervical
  • Chronic lymphocytic leukemia (CLL)
  • Chronic myelogenous (or myeloid) leukemia (CML)
  • Colorectal
  • Endometrial
  • Gastrointestinal stromal tumor (GIST)
  • Genitourinary indications
  • Gliomas
  • Head and neck
  • Hepatocellular carcinoma
  • Idiopathic thrombocytopenic purpura (ITP)
  • Lymphoma
  • Malignant ascites
  • Melanoma
  • Multiple myeloma
  • Myelodysplastic syndrome
  • Neuroendocrine tumors
  • NSCLC
  • Oral mucositis
  • Ovarian
  • Pancreatic
  • Pediatrics
  • Prostate
  • Renal cell carcinoma
  • Sarcoma
  • Solid tumors
  • Thoracic indications

View a list of our completed clinical trials, or review case studies for a few of our trials.